
Pantonof IV Injection
Marketer
Cenofi Healthcare Pvt Ltd
Salt Composition
Pantoprazole (40mg)
Overview Pantonof IV Injection
GastriCalm IV is an intravenous medication that suppresses gastric acid production. It's indicated for various acid-related gastrointestinal disorders, including gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome, offering symptomatic relief and promoting healing. GastriCalm IV also prevents stress ulcers in critically ill patients and is pre-anesthetically administered to mitigate aspiration risks. Classified as a proton pump inhibitor (PPI), it's administered intravenously by a medical professional only when deemed superior to oral formulations by your physician. Dosage is individualized based on your condition and response. Treatment duration is determined by your doctor; consistent use, as prescribed, is crucial even with rapid symptom resolution. Lifestyle modifications, such as frequent, smaller meals and avoidance of caffeine, spicy foods, and fatty foods, can enhance treatment effectiveness. Common, generally mild, side effects include nausea, vomiting, headache, dizziness, gas, diarrhea, abdominal pain, and thrombophlebitis (vein inflammation). Persistent or bothersome side effects warrant medical attention. Prolonged use, particularly exceeding one year, may elevate the risk of bone fractures, especially at higher doses. Discuss bone health strategies, such as calcium and vitamin D supplementation, with your doctor. GastriCalm IV is contraindicated in individuals with severe hepatic impairment, those on HIV medications, those with prior PPI allergy, or pre-existing osteoporosis. Pregnant or lactating women should consult their physician before use. Alcohol consumption should be avoided due to its acid-stimulating properties. Refrain from operating machinery if dizziness or drowsiness occurs.
Primary Ingredients of Pantonof IV Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Pantonof IV Injection
Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.
Major Benefits of Pantonof IV Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Pantonof IV Injection:
- Diarrhea
- Flatulence
- Headache
- Joint pain
- Nausea
- Stomach pain
- Vomiting
- Dizziness
- Thrombophlebitis
How to use Pantonof IV Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Pantonof IV Injection works:
Gastric acid secretion is diminished by Pantonof IV Injection, a proton pump inhibitor, thus alleviating heartburn and acid indigestion.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol while using Pantonof IV Injection.
PregnancyCONSULT YOUR DOCTOR
Administering Pantonof IV Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Administration of Pantonof IV Injection during lactation appears to pose minimal risk to the infant, based on currently available, albeit limited, human data.
DrivingCONSULT YOUR DOCTOR
Pantonof IV Injection's effect on driving ability is undetermined. Refrain from operating a vehicle if experiencing symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Pantonof IV Injection poses no safety concerns for patients with renal impairment; no dosage modification is necessary.
LiverCAUTION
Patients with significant hepatic impairment should receive Pantonof IV Injection cautiously, potentially requiring dosage modification. Physician consultation is advised.
What if you forget to take Pantonof IV Injection :
Omit a Pantonof IV Injection dose? Seek your physician's advice.
Facts to Know About Pantonof IV Injection
| Label | Value |
|---|---|
| Chemical Classification | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Type of Therapy | Gastrointestinal System |
| Behavior Class | Gastric acid suppressants |
